An interview with Dr. Tiffany Amariuta-Bartell: Progress in precision medicine for all
MIT Science Policy Review · 07.08.2026 · 7 · 107-111
DOI: 10.38105/spr.aiis8xtdy6 ↗Kurz gefasst
Fachartikel in der Zeitschrift MIT Science Policy Review, online erschienen am 07.08.2026. Verfasst von Everlyne Mutua und 1 weiteren Autor:innen.
Abstract (Originalsprache)
MIT Science Policy Review spoke to Dr. Tiffany Amariuta-Bartell about how we can govern genomic science so that the potential of precision medicine, predicting and preventing disease on an individual level, is realized responsibly and equitably across populations. Amariuta-Bartell is an assistant professor at the Hali{}ci{}ou{g}lu Data Science Institute and the Division of Biomedical Informatics within the Department of Medicine at UC San Diego. The focus of her current research is to develop multi-ancestry genetic prediction methods that allow for powerful disease inferences for underrepresented populations cite{noauthor_amariuta_nodate}. In 2023, she was awarded the Hartwell Individual Biomedical Research Award. She holds an undergraduate degree in biological engineering from Massachussets Institute of Technology (MIT) and a Ph.D. in bioinformatics and integrative genomics from Harvard Medical School.
Zitieren
APA
Mutua, E., & Dhaliwal, G. (2026). An interview with Dr. Tiffany Amariuta-Bartell: Progress in precision medicine for all. MIT Science Policy Review, 7, 107-111. https://doi.org/10.38105/spr.aiis8xtdy6
Vancouver
Mutua E, Dhaliwal G. An interview with Dr. Tiffany Amariuta-Bartell: Progress in precision medicine for all. MIT Science Policy Review. 2026;7:107-111. doi:10.38105/spr.aiis8xtdy6
BibTeX
@article{Mutua2026,
author = {Mutua, Everlyne and Dhaliwal, Gurman},
title = {An interview with Dr. Tiffany Amariuta-Bartell: Progress in precision medicine for all},
journal = {MIT Science Policy Review},
year = {2026},
volume = {7},
pages = {107--111},
doi = {10.38105/spr.aiis8xtdy6}
}
EUVIMED